These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1907907

  • 21. Clinical efficacy and safety of gabapentin.
    Ramsay RE.
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [Abstract] [Full Text] [Related]

  • 22. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study.
    Mayer T, Schütte W, Wolf P, Elger CE.
    Acta Neurol Scand; 1999 Jan; 99(1):1-7. PubMed ID: 9925232
    [Abstract] [Full Text] [Related]

  • 23. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A, Fischer J, Labar DR, Harden C, Cantrell D, Uthman BM, Sackellares JC, Abou-Khalil B, Ramsay RE, Hayes A, Greiner M, Garofalo E, Pierce M.
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Long-term study with gabapentin in patients with drug-resistant epileptic seizures.
    Sivenius J, Ylinen A, Kälviäinen R, Riekkinen PJ.
    Arch Neurol; 1994 Oct; 51(10):1047-50. PubMed ID: 7945002
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group.
    Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258
    [Abstract] [Full Text] [Related]

  • 30. Gabapentin: discussion.
    Fromm GH.
    Epilepsia; 1994 May; 35 Suppl 5():S77-80. PubMed ID: 8039476
    [Abstract] [Full Text] [Related]

  • 31. Long-term treatment with gabapentin for partial epilepsy.
    Ojemann LM, Wilensky AJ, Temkin NR, Chmelir T, Ricker BA, Wallace J.
    Epilepsy Res; 1992 Nov; 13(2):159-65. PubMed ID: 1464301
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
    McLean MJ, Morrell MJ, Willmore LJ, Privitera MD, Faught RE, Holmes GL, Magnus-Miller L, Bernstein P, Rose-Legatt A.
    Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study.
    Appleton R, Fichtner K, LaMoreaux L, Alexander J, Maton S, Murray G, Garofalo E.
    Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405
    [Abstract] [Full Text] [Related]

  • 38. A beneficial effect on mood in partial epilepsy patients treated with gabapentin.
    Harden CL, Lazar LM, Pick LH, Nikolov B, Goldstein MA, Carson D, Ravdin LD, Kocsis JH, Labar DR.
    Epilepsia; 1999 Aug; 40(8):1129-34. PubMed ID: 10448827
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.